Literature DB >> 268657

Modulation of acetylcholine receptor by antibody against the receptor.

S Heinemann, S Bevan, R Kullberg, J Lindstrom, J Rice.   

Abstract

Antibody against acetylcholine receptor induces an increase in the rate of degradation of acetylcholine receptors on a mouse cell line (BC(3)H-1) and cultured rat skeletal muscle. The increased rate of degradation results in a lowered density of acetylcholine receptors on muscle membrane and a lowered sensitivity to iontophoretically applied acetylcholine. The modulation of acetylcholine receptor is energy, temperature, and time dependent and may be related to antigenic modulation found in other systems. Acetylcholine noise analysis demonstrates that antibody against acetylcholine receptor reduces the channel mean conductance and mean open time slightly. It is concluded that antibody binds to the acetylcholine receptor, impairs its function, and induces receptor degradation. This results in a lowered density of acetylcholine receptor and a lowered sensitivity to acetylcholine. Patients with myasthenia gravis have antibodies to their acetylcholine receptor in their serum. Antigenic modulation of receptor in the muscle of patients with myasthenia gravis could contribute to the observed decrease in amplitudes of miniature endplate potentials and in muscle acetylcholine sensitivity, and the symptoms of muscular weakness.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 268657      PMCID: PMC431419          DOI: 10.1073/pnas.74.7.3090

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  THE DEVELOPMENT OF ACETYLCHOLINE SENSITIVITY IN NERVE-FREE SEGMENTS OF SKELETAL MUSCLE.

Authors:  B KATZ; R MILEDI
Journal:  J Physiol       Date:  1964-03       Impact factor: 5.182

2.  AN ELECTROPHYSIOLOGICAL INVESTIGATION OF NEUROMUSCULAR TRANSMISSION IN MYASTHENIA GRAVIS.

Authors:  D ELMQVIST; W W HOFMANN; J KUGELBERG; D M QUASTEL
Journal:  J Physiol       Date:  1964-11       Impact factor: 5.182

3.  Acetylcholine receptor degradation measured by pulse chase labelling.

Authors:  J P Merlie; J P Changeux; F Gros
Journal:  Nature       Date:  1976-11-04       Impact factor: 49.962

4.  Modulation of TL (thymus-leukemia) antigens by Fab-fragments of TL antibody.

Authors:  M E Lamm; E A Boyse; L J Old; B Lisowska-Bernstein; E Stockert
Journal:  J Immunol       Date:  1968-07       Impact factor: 5.422

5.  Acetylcholine receptor metabolism in a nonfusing muscle cell line.

Authors:  J Patrick; J McMillan; H Wolfson; J C O'Brien
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

6.  Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.

Authors:  J M Lindstrom; M E Seybold; V A Lennon; S Whittingham; D D Duane
Journal:  Neurology       Date:  1976-11       Impact factor: 9.910

7.  The action of tubocurarine and atropine on the normal and denervated rat diaphragm.

Authors:  R Beránek; F Vyskocil
Journal:  J Physiol       Date:  1967-01       Impact factor: 5.182

8.  Kinetics of biosynthesis of acetylcholine receptor and subsequent incorporation into plasma membrane of cultured chick skeletal muscle.

Authors:  P N Devreotes; J M Gardner; D M Fambrough
Journal:  Cell       Date:  1977-03       Impact factor: 41.582

9.  The statistical nature of the acetycholine potential and its molecular components.

Authors:  B Katz; R Miledi
Journal:  J Physiol       Date:  1972-08       Impact factor: 5.182

10.  Voltage clamp analysis of acetylcholine produced end-plate current fluctuations at frog neuromuscular junction.

Authors:  C R Anderson; C F Stevens
Journal:  J Physiol       Date:  1973-12       Impact factor: 5.182

View more
  53 in total

1.  Treatment of passively transferred experimental autoimmune myasthenia gravis using papain.

Authors:  K Poulas; T Tsouloufis; S J Tzartos
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 2.  Immunopathologic events at the endplate in myasthenia gravis.

Authors:  T Ashizawa; S H Appel
Journal:  Springer Semin Immunopathol       Date:  1985

Review 3.  Myasthenia gravis: an autoimmune response against the acetylcholine receptor.

Authors:  Y M Graus; M H De Baets
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 4.  The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.

Authors:  S J Tzartos; M T Cung; P Demange; H Loutrari; A Mamalaki; M Marraud; I Papadouli; C Sakarellos; V Tsikaris
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

Review 5.  Specificities of autoantibodies in autoimmune receptor diseases.

Authors:  M H De Baets
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

6.  Human systemic lupus erythematosus sera contain antibodies against cell-surface protein(s) that share(s) epitope(s) with DNA.

Authors:  L Jacob; M A Lety; J F Bach; D Louvard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

7.  Action of antibodies directed against the acetylcholine receptor on channel function at mouse and rat motor end-plates.

Authors:  J O Dolly; M Gwilt; G Lacey; J Newsom-Davis; A Vincent; P Whiting; D W Wray
Journal:  J Physiol       Date:  1988-05       Impact factor: 5.182

Review 8.  Myasthenia gravis--current concepts.

Authors:  C Herrmann; J M Lindstrom; J C Keesey; D G Mulder
Journal:  West J Med       Date:  1985-06

9.  Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.

Authors:  A Bionda; M H De Baets; S J Tzartos; J M Lindstrom; W O Weigle; A N Theophilopoulos
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

10.  Acetylcholine receptor and thymus in experimental autoimmune myasthenia gravis and experimental myositis.

Authors:  S Ueno; K Wada; J Kang; M Takahashi; S Tarui
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.